Mayne Pharma reaches settlement in class action over antitrust probe
SYDNEY: Generic drug maker Mayne Pharma has resolved a shareholder class action centred on disclosures
SYDNEY: Generic drug maker Mayne Pharma has resolved a shareholder class action centred on disclosures